Before Mastering Taobao, Douyin, and Kuaishou Marketing Tactics, Learn Product and Data Thinking First | Ronghui
In the wave of data-driven marketing, marketing has become product and operations.
高榕创投
@gaorong
创造美好生活
522 articles
Articles
Gaorong Report · July | Gaorong Ventures Ranked Top 5 VC Funds by Returns at 2020 China Fund of Funds Summit, Decoding Consumer Investment Logic Under the "Dual Circulation" Development Paradigm
Investment in consumer, technology and innovation, and healthcare sectors continues to gain recognition.
SmartX Closes Nearly RMB 200 Million in Series B+ and C Funding to Accelerate Coverage of Mid-to-High-End Enterprise Cloud Market
Accelerating independent innovation and scenario expansion for enterprise cloud core engines, building a solid foundation for digital transformation and "new infrastructure."
Hyperparameter's Yongsheng Liu: Exploring Evolutionary AI in Virtual Worlds
Build virtual worlds with different scenarios, and let AI learn and evolve within them.
Rongbao · June | Gaotu Techedu Marks 6th Anniversary by "Redefining the Large Live-Streaming Class Model," YITU's Leo Zhu Publishes Signed Op-Ed in *People's Daily*
Never stop moving forward — create value, explore the unknown.
Equipping Autonomous Driving, Robotics, and Virtual Entertainment with Brains... How Intelligent Agents Are Reshaping the Future | Ronghui
Five Tech Leaders Discuss: How AI Agents Cross from Virtual to Physical to Bring Greater Benefits to Humanity
AIPARK, a leading smart parking company, has completed its Series C financing round led by Gaorong Ventures.
Using AI technology to usher in the era of Smart Parking 5.0.
When Traffic Costs More Than Gold, How Do You Actually Drive Growth? | Ronghui
Hunting for traffic in the "stock era."
Rongbao · May | Large-Memory Computing, Autonomous Driving and Other New Technologies Accelerate Adoption; Integration of Goods and Services Emerges as New Consumption Trend
Underlying technological innovation and new demographics are driving infinite possibilities.
Shuimu BioSciences Announces Angel Round to Build World-Class Next-Generation Drug Discovery Platform
Shuimu BioSciences has built Asia's first commercial protein structure analysis platform centered on 300kV top-tier cryo-EM, dedicated to using breakthrough technology to dramatically accelerate drug discovery and improve the druggability of difficult targets.